Literature DB >> 19912199

Application of mesenchymal stromal cells in urological diseases.

Katrin Montzka1, Axel Heidenreich.   

Abstract

The application of stem cells and their use in tissue-engineering approaches is emerging in clinical therapeutic intervention strategies. The use of adult stem cells, either autologous or allogenic, does not raise ethical concerns, in contrast to embryonic stem cells. Mesenchymal stromal cells (MSCs) can be easily obtained from bone marrow or from adipose tissue and further expanded in vitro. Due to their differentiation capacity, MSCs are very attractive for tissue engineering purposes. Furthermore, MSCs secrete a variety of mediators that have beneficial effects on the regenerating tissue. In this review we give an insight into stem cell hierarchy, define the properties of MSCs and summarize recent reports of their administration in urological diseases.

Entities:  

Mesh:

Year:  2009        PMID: 19912199     DOI: 10.1111/j.1464-410X.2009.09077.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  7 in total

Review 1.  Stem Cell Therapy for Interstitial Cystitis/Bladder Pain Syndrome.

Authors:  Aram Kim; Dong-Myung Shin; Myung-Soo Choo
Journal:  Curr Urol Rep       Date:  2016-01       Impact factor: 3.092

2.  Mesenchymal Stem Cell Therapy Alleviates Interstitial Cystitis by Activating Wnt Signaling Pathway.

Authors:  Miho Song; Jisun Lim; Hwan Yeul Yu; Junsoo Park; Ji-Youn Chun; Jaeho Jeong; Jinbeom Heo; Hyunsook Kang; YongHwan Kim; Yong Mee Cho; Seong Who Kim; Wonil Oh; Soo Jin Choi; Sung-Wuk Jang; Sanghyeok Park; Dong-Myung Shin; Myung-Soo Choo
Journal:  Stem Cells Dev       Date:  2015-04-09       Impact factor: 3.272

Review 3.  Potential therapeutic applications of muscle-derived mesenchymal stem and progenitor cells.

Authors:  Wesley M Jackson; Leon J Nesti; Rocky S Tuan
Journal:  Expert Opin Biol Ther       Date:  2010-04       Impact factor: 4.388

4.  Tendon tissue engineering: adipose-derived stem cell and GDF-5 mediated regeneration using electrospun matrix systems.

Authors:  R James; S G Kumbar; C T Laurencin; G Balian; A B Chhabra
Journal:  Biomed Mater       Date:  2011-03-24       Impact factor: 3.715

Review 5.  Stem cell applications in military medicine.

Authors:  Gregory T Christopherson; Leon J Nesti
Journal:  Stem Cell Res Ther       Date:  2011-10-19       Impact factor: 6.832

6.  Evaluation of mesenchymal stem cells in treatment of infertility in male rats.

Authors:  Amal I Hassan; Sally S Alam
Journal:  Stem Cell Res Ther       Date:  2014-11-23       Impact factor: 6.832

7.  Small hypoxia-primed mesenchymal stem cells attenuate graft-versus-host disease.

Authors:  YongHwan Kim; Hye Jin Jin; Jinbeom Heo; Hyein Ju; Hye-Yeon Lee; Sujin Kim; Seungun Lee; Jisun Lim; Sang Young Jeong; JiHye Kwon; Miyeon Kim; Soo Jin Choi; Wonil Oh; Yoon Sun Yang; Hyun Ho Hwang; Hwan Yeul Yu; Chae-Min Ryu; Hong Bae Jeon; Dong-Myung Shin
Journal:  Leukemia       Date:  2018-05-22       Impact factor: 11.528

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.